Quantcast

Latest Treatments of Parkinson's Disease Stories

2011-06-09 15:09:04

Few treatments for Parkinson's disease (PD) restore function for extended periods.

2011-06-09 08:30:00

ABBOTT PARK, Ill., June 9, 2011 /PRNewswire/ --Interim efficacy and safety results from a long-term, 54-week, Phase III open-label study of Abbott's investigational treatment for advanced Parkinson's disease showed that patients treated with levodopa-carbidopa intestinal gel (LCIG) for 12 weeks reported a decrease in "off" time and an increase in "on" time without troublesome dyskinesias.

2011-05-23 01:00:00

OXFORD, England, May 23, 2011 /PRNewswire-FirstCall/ -- - Six-Month Data From Third Cohort Presented at ASGCT 14th Annual Meeting - - Highest Efficacy Results to Date With 43% Average Motor Function Improvement - Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), a leading gene therapy company, announces that new data from the on-going Phase I/II trial of ProSavin(R) for the treatment of Parkinson's disease (PD) were presented at the American Society of Gene...

2011-04-26 08:00:00

INDIANAPOLIS and MINNEAPOLIS, April 26, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Medtronic, Inc.

2011-03-17 12:34:36

A first-of-its-kind study of gene therapy in the treatment of Parkinson's disease determined that half of all patients who received the treatment had "clinically meaningful improvements" of their symptoms within six months of surgery.

2011-03-16 17:30:00

DETROIT, March 16, 2011 /PRNewswire/ -- A first-of-its-kind study of gene therapy in the treatment of Parkinson's disease determined that half of all patients who received the treatment had "clinically meaningful improvements" of their symptoms within six months of surgery. "The study demonstrates that the promise of gene therapy for neurodegenerative disorders has become a reality," says study lead author and co-principal investigator Peter LeWitt, M.D., director of movement disorders at...

2011-03-16 17:30:00

FORT LEE, N.J., March 16, 2011 /PRNewswire/ -- Neurologix, Inc.

2011-03-09 12:59:00

NESS ZIONA, Israel, March 9, 2011 /PRNewswire/ -- NeuroDerm, Ltd. announced today the enrollment of the first group of patients in its Phase I/II clinical trial of ND0611, a new patch for the treatment of Parkinson's disease.


Word of the Day
coulisse
  • One of the side scenes of the stage in a theater, or the space included between the side scenes.
  • The outside stock exchange, or “curb market,” of Paris.
  • A flute or groove on the blade of a sword.
  • A section of stage scenery placed in a wing of a theatre.
The word 'coulisse' comes from a French word meaning "sliding door".
Related